Important: This article is for educational purposes only and is not medical advice. Pediatric care should be directed by a pediatrician, pediatric specialist, or other qualified clinician. Most CBD products are not formulated, tested, or marketed for children. Never give a child any CBD product without consulting the treating clinician.
Pediatric CBD use is one of the highest-stakes topics in the CBD conversation. The FDA has been particularly active in pursuing companies marketing CBD products to or for children, and there are good reasons for that. The honest answer is that consumer CBD is not pediatric medicine, and pediatric medical decisions should run through pediatricians, not wellness products.
The short version
- Most CBD products are not for children. Consumer CBD oils, gummies, capsules, and tinctures are dietary supplements marketed for adult use, not pediatric medications.
- Epidiolex is the exception. It is an FDA-approved prescription cannabidiol drug for children one year and older with seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex. It is a prescription drug, not a consumer CBD product, and is given under neurologist supervision.
- The FDA has issued warning letters and consumer advisories about CBD products marketed to children, particularly those with packaging or branding that appeals to minors (gummies that look like candy, in particular).
What the FDA has said about pediatric CBD
The FDA has been clear:
- Consumer CBD products have not been evaluated for safety or efficacy in children
- Marketing CBD products to or for children is an enforcement priority
- Pediatric ingestion of cannabinoid products (THC in particular) has produced thousands of poison-control calls and hospitalizations, often when children mistake CBD or delta-8 gummies for candy
The agency’s communications have been particularly direct on packaging that mimics popular candy or snack brands.
Epidiolex is different
Epidiolex deserves its own paragraph because of the confusion it causes. Epidiolex is:
- An FDA-approved prescription drug containing pharmaceutical-grade cannabidiol
- Approved for children one year and older with seizures associated with three rare conditions: Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex
- Manufactured to pharmaceutical standards
- Dosed by weight under neurologist supervision
- The result of formal clinical trials in the populations it is approved for
Consumer CBD oils, gummies, and tinctures are not Epidiolex. The pharmacology, manufacturing, dosing, and FDA approval status are all different. A neurologist treating Lennox-Gastaut syndrome may prescribe Epidiolex; that does not transfer to a recommendation for any consumer CBD product.
Why pediatric CBD requires special caution
A few specific concerns:
- Developing brains. The brain develops into the mid-20s, and the long-term effects of cannabinoid exposure on developing brains are not well characterized. Heavy adolescent cannabis use specifically has been associated with worse cognitive and psychiatric outcomes in some studies, including increased psychosis risk in vulnerable individuals.
- Drug interactions. Children with chronic conditions are often on multiple medications. CBD shares liver-enzyme pathways with many of them.
- Accidental exposure. Cannabinoid gummies have been a major source of pediatric poison-control calls. Storage and packaging matter.
- Quality variability. Independent testing of consumer CBD products has repeatedly found that label claims do not always match contents. Pediatric exposure to mislabeled cannabinoid products is particularly concerning.
What about ADHD, autism, anxiety, sleep in children?
The driving question is often a specific pediatric concern:
- ADHD: Stimulant and non-stimulant medications, behavioral therapy, classroom and parent-training interventions all have evidence. CBD has not been shown to be effective for ADHD in children.
- Autism spectrum disorder: Care includes early intervention, applied behavior analysis, speech and occupational therapy, and selected medications for specific co-occurring conditions. Some research has examined CBD or CBD-rich extracts in autism contexts, but the evidence is preliminary and not a basis for treatment recommendations.
- Pediatric anxiety: Cognitive-behavioral therapy is first-line. Selected medications when appropriate, prescribed by a pediatric clinician.
- Sleep: Sleep hygiene, behavior interventions, treating contributing causes; medications including melatonin sometimes used under clinician guidance.
These are all conversations with the pediatrician or pediatric specialist, not with a CBD product label.
What about cannabis-related products in pediatric epilepsy?
This is the most legitimate use case in pediatric cannabinoid medicine. Families with children who have severe drug-resistant epilepsy, particularly the conditions Epidiolex is approved for, may have meaningful conversations with their neurologist about Epidiolex. This is prescription medicine under specialist supervision — not a recommendation for consumer CBD.
Drug-interaction considerations
CBD shares liver-enzyme pathways (CYP3A4, CYP2C19) with several medications used in pediatric care, including some seizure medications (where the interactions matter clinically), antidepressants used in some pediatric contexts, and others. A pediatric clinician should be involved in any decision about cannabinoid products.
What we offer at New Phase Blends
We make third-party-tested CBD products designed for general wellness use in adults. They are not formulated, tested, or marketed for children. We do not recommend giving CBD products to children outside of a pediatric clinician’s directed care plan.
Frequently asked questions
Are CBD products safe for children? Most consumer CBD products are not formulated, tested, or marketed for children. The FDA has issued warning letters about CBD products marketed to minors. Pediatric CBD use should be discussed with a pediatrician.
What about Epidiolex? Epidiolex is an FDA-approved prescription cannabidiol drug for specific pediatric seizure conditions, given under neurologist supervision. It is not the same as consumer CBD products.
Can I give my child a CBD gummy for sleep? Talk to your pediatrician first. Pediatric sleep concerns have specific evidence-based approaches, and consumer CBD is not among them.
My child accidentally ate a CBD gummy. What should I do? Call Poison Control (1-800-222-1222 in the U.S.) and follow their guidance. Pediatric cannabinoid ingestions have been a major poison-control source and warrant evaluation.
Disclaimer: The statements made on this page have not been evaluated by the Food and Drug Administration. Our products are not intended to diagnose, treat, cure, or prevent any disease and are not intended for pediatric use. The information here is for educational purposes only and is not a substitute for advice from a licensed medical professional.
